Filing Details

Accession Number:
0001209191-18-033088
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-24 17:28:17
Reporting Period:
2018-03-08
Accepted Time:
2018-05-24 17:28:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1711279 Krystal Biotech Inc. KRYS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1339375 A Antony Riley 2100 Wharton Street
Suite 701
Pittsburgh PA 15203
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-22 2,800 $10.75 2,800 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-03-08 25,000 $0.00 25,000 $9.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2028-03-08 No 4 A Direct
Footnotes
  1. The options were awarded on March 8, 2018 and vest ratably over a four-year period.